UFP Technologies, Inc. (UFPT)
305.06
-0.85
(-0.28%)
USD |
NASDAQ |
Nov 13, 16:00
305.30
+0.24
(+0.08%)
Pre-Market: 19:59
UFP Technologies Enterprise Value : 2.459B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.459B |
| November 12, 2026 | 2.466B |
| November 11, 2026 | 2.529B |
| November 10, 2026 | 2.529B |
| November 09, 2026 | 2.566B |
| November 06, 2026 | 2.447B |
| November 05, 2026 | 2.419B |
| November 04, 2026 | 2.651B |
| November 03, 2026 | 2.268B |
| November 02, 2026 | 2.296B |
| October 30, 2026 | 2.300B |
| October 29, 2026 | 2.368B |
| October 28, 2026 | 2.312B |
| October 27, 2026 | 2.380B |
| October 26, 2026 | 2.352B |
| October 23, 2026 | 2.387B |
| October 22, 2026 | 2.399B |
| October 21, 2026 | 2.343B |
| October 20, 2026 | 2.353B |
| October 19, 2026 | 2.368B |
| October 16, 2026 | 2.355B |
| October 15, 2026 | 2.398B |
| October 14, 2026 | 2.351B |
| October 13, 2026 | 2.376B |
| October 12, 2026 | 2.388B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.335B |
| October 08, 2026 | 2.316B |
| October 07, 2026 | 2.365B |
| October 06, 2026 | 2.442B |
| October 05, 2026 | 2.477B |
| October 02, 2026 | 2.425B |
| October 01, 2026 | 2.381B |
| September 30, 2026 | 2.395B |
| September 29, 2026 | 2.427B |
| September 28, 2026 | 2.445B |
| September 25, 2026 | 2.417B |
| September 24, 2026 | 2.439B |
| September 23, 2026 | 2.353B |
| September 22, 2026 | 2.336B |
| September 21, 2026 | 2.309B |
| September 18, 2026 | 2.270B |
| September 17, 2026 | 2.261B |
| September 16, 2026 | 2.292B |
| September 15, 2026 | 2.261B |
| September 14, 2026 | 2.281B |
| September 11, 2026 | 2.280B |
| September 10, 2026 | 2.276B |
| September 09, 2026 | 2.285B |
| September 08, 2026 | 2.305B |
| September 04, 2026 | 2.364B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.161B |
| Abbott Laboratories | 215.41B |
| AngioDynamics, Inc. | 480.34M |
| Alphatec Holdings, Inc. | 1.622B |
| AtriCure, Inc. | 2.804B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 20.62M |
| Revenue (Quarterly) | 172.43M |
| Total Expenses (Quarterly) | 151.82M |
| EPS Diluted (Quarterly) | 2.641 |
| Gross Profit Margin (Quarterly) | 29.44% |
| Profit Margin (Quarterly) | 11.96% |
| Earnings Yield | 3.22% |
| Operating Earnings Yield | 4.21% |
| Normalized Earnings Yield | 3.203 |